According to the data released by the Election Commission, almost thirty-five pharmaceutical companies in India contributed Rs 1,000 crore to political parties through electoral bonds
Sun Pharmaceutical Industries Limited has recently announced that the Australian Therapeutic Goods Administration (TGA) has granted regulatory approval for Winlevi, a clascoterone cream.
Arch Biopartners Inc, a late-stage clinical trial company focused on preventing inflammation and acute organ injury
The Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024 guidelines have been recently released, and the Indian pharmaceutical sector sees it as a practical approach to promoting ethical marketing practices in the country.
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company specializing in developing novel therapeutics for NASH, has announced that the US Food and Drug Administration (FDA) has granted accelerated approval for Rezdiffra
Forty-nine district hospitals have established geriatric wards in the past three months to cater to patients requiring specialized care. These hospitals have also introduced geriatric clinics for elderly patients seeking OPD services.
The healthcare sector has been one of the areas most affected by the 2023 mega breaches, which saw over a million records stolen.
Sakra World Hospital, a joint venture between SECOM and Toyota Tsusho Corporation (TTC), has announced plans to establish a healthcare facility in Banaswadi, Bengaluru, with an expected investment of Rs 1,000 crore.
Union Minister Dr Jitendra Singh recently addressed the “Doctors’ Sammelan†organized by BJP, where he shared his perspective on the challenges faced by the healthcare sector in Jammu & Kashmir.
For the past eighteen months, Gujarat's pharmaceutical companies have been grappling with concerns over price erosion in the US market. However, recent developments indicate a welcome resurgence in their US market revenues.